[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369049-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369049-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","genetic-testing-among-black-and-white-patients-with-advanced-prostate-cancer-a-retrospective-analysis-of-testing-utilization-and-referral-patterns","Genetic Testing Among Black and White Patients With Advanced Prostate Cancer - A Retrospective Analysis of Testing Utilization and Referral Patterns","","Genetic testing is recommended in advanced prostate cancer yet remains underutilized, with documented disparities affecting Black patients. This retrospective analysis evaluates genetic testing completion by race, using Henry Ford Health electronic medical records. The study quantifies somatic and germline testing completion in stage IV cases and examines genetic counseling referral rates and attendance. Multivariable logistic regression and exploratory Kaplan-Meier comparisons assess associations and survival differences.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/genetic-testing-among-black-and-white-patients-with-advanced-prostate-cancer-a-retrospective-analysis-of-testing-utilization-and-referral-patterns/369049/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/genetic-testing-among-black-and-white-patients-with-advanced-prostate-cancer-a-retrospective-analysis-of-testing-utilization-and-referral-patterns/369049.png","ImageObject",300,407,{"name":42,"@type":43},"acoobca","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study purpose regarding genetic testing in advanced prostate cancer?","Question",{"text":63,"@type":64},"To assess genetic testing completion rates by race, given that genetic testing is recommended but underutilized and that disparities affecting Black patients are known.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were testing outcomes measured in this retrospective study?",{"text":68,"@type":64},"Henry Ford Health electronic medical records were queried for new prostate cancer diagnoses from 1/1/2017 to 6/30/2022. Primary outcome was completion of somatic and/or germline testing in stage IV cases, with secondary outcomes including genetic counseling referral and attendance.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the study find about somatic and germline testing differences by race?",{"text":72,"@type":64},"Black patients had higher somatic testing rates overall, with comparable overall germline testing. However, in metastatic (M1) cases, germline testing was lower among Black patients despite higher referral rates, indicating barriers beyond referral and access.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369049,1790847394,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},3985747870733,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","The Prostate   \nORIGINAL ARTICLE   \nGenetic Testing Among Black and White Patients With Advanced Prostate Cancer: A Retrospective Analysis of Testing Utilization and Referral Patterns  \nKyle C. McElyea1  | James P. Purtell1 | Avery K. Supernois1 | Courtney M. Rose2 | Farhan Ibrahim1 | Mohammed A. Baseer3 | Sunita Ghosh2,4 | Clara Hwang1,4,5  \n1Department of Internal Medicine, Division of Hematology and Oncology, Henry Ford Health, Detroit, Michigan, USA | 2Department of Public Health Sciences, Division of Biostatistics, Henry Ford Health, Detroit, Michigan, USA | 3Department of Public Health Sciences, Henry Ford Health, Detroit, Michigan, USA | 4Michigan State University, College of Human Medicine, East Lansing, Michigan, USA | 5Wayne State University, School of Medicine, Detroit, Michigan, USA  \nCorrespondence: Clara Hwang ([chwang2@hfhs.org](chwang2@hfhs.org))  \nReceived: 2 August 2025 | Revised: 9 November 2025 | Accepted: 26 November 2025  \nKeywords: genetic counseling | germline | healthcare disparities | oncology care access | somatic  \nABSTRACT  \nPurpose: Genetic testing is recommended but underutilized in advanced prostate cancer. Given known disparities affecting Black patients, we assessed genetic testing completion rates by race.  \nMethods: Henry Ford Health's electronic medical record was queried for new prostate cancer diagnoses (1/1/2017–6/30/2022) . The primary outcome was completion of somatic and/or germline testing in stage IV cases. Secondary outcomes included genetic counseling referrals and attendance. Multivariable logistic regression assessed associations with baseline variables. Kaplan‐Meier analysis was used for exploratory survival comparisons.  \nResults: Among 452 stage IV patients (150 Black, 302 White), Black patients had higher somatic (30.7% vs. 18.9%, p = 0.00489) and comparable germline testing rates (16.7% vs. 21.2%, p = 0.255) . In M1 cases (N= 297), germline testing was lower among Black patients (14.8% vs. 25.4%, p = 0.0329) despite higher referral rates (32.0% vs 22.2%, p = 0.0241) and similar counseling attendance (45.8% and 43.3%, p = 0.786) . No significant racial differences were seen in germline testing for N1 cases (N= 155, 21.4% vs 14.2%, p = 0.274), or somatic testing for M1 (36.1% vs 25.9%, p = 0.0644) or N1 (16.7% vs 7.1%, p = 0.0728) subgroups. M1 patients that completed testing had improved survival (p = 0.0352), while no survival difference by testing in N1 disease or race was observed.  \nConclusions: Genetic testing uptake in this advanced prostate cancer cohort was low overall. Notably, Black patients had higher rates of somatic testing, an equitable finding given historically higher prostate cancer‐specific mortality. Germline testing was comparable overall but remained lower among Black patients with metastatic disease, indicating that additional decisionaland systemic barriers persist beyond access to care and referrals to genetic counseling.  \nInsurance disparities and lower census tract‐estimated income represent the largest structural differences between cohorts, with observed equity likely supported by broad coverage of commercial testing. Together, these results indicate that equitable testing utilization is achievable through consistent access frameworks, while residual disparities in germline testing warrant targeted intervention at both the patient and healthcare delivery levels.  \nThis is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.  \n© 2025 The Author(s) . The Prostate published by Wiley Periodicals LLC.  \nThe Prostate, 2026; 86:440–450 440  \n[https://doi.org/10.1002/pros.70103](https://doi.org/10.1002/pros.70103)  \n1 | Introduction  \nCompletion of genetic testing in advanced prostate cancer can guide treatment decisions, tailor availab","cbCaiphAgUvobkQE","https://ap.wps.com/l/cbCaiphAgUvobkQE","pdf",538191,11,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Clinical utility of genetic testing in advanced prostate cancer\n## Guideline recommendations for germline and somatic testing","[{\"question\":\"What was the study purpose regarding genetic testing in advanced prostate cancer?\",\"answer\":\"To assess genetic testing completion rates by race, given that genetic testing is recommended but underutilized and that disparities affecting Black patients are known.\"},{\"question\":\"How were testing outcomes measured in this retrospective study?\",\"answer\":\"Henry Ford Health electronic medical records were queried for new prostate cancer diagnoses from 1/1/2017 to 6/30/2022. Primary outcome was completion of somatic and/or germline testing in stage IV cases, with secondary outcomes including genetic counseling referral and attendance.\"},{\"question\":\"What did the study find about somatic and germline testing differences by race?\",\"answer\":\"Black patients had higher somatic testing rates overall, with comparable overall germline testing. However, in metastatic (M1) cases, germline testing was lower among Black patients despite higher referral rates, indicating barriers beyond referral and access.\"}]","Genetic Testing Among Black and White Patients With Advanced Prostate Cancer - A Retrospective Analysis of Testing Utilization and Referral Patterns | PDF",1790180369,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1fc5d968e25004684341f452c46f9bef.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0d71a28fe8abaf263dbc618df448f066.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f2d7de6e6dea38b3c2650c0a43a7032e.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1eb6d40b9a30e02352b39b3f73b91667.webp",980,1287]